- Made Scientific and NJIT have partnered to co-develop graduate-level bioprocessing courses focused on cell and gene therapy manufacturing.
- The program, launching in Spring 2027, aims to prepare students with practical, industry-aligned skills for CGT manufacturing environments.
Made Scientific has announced a partnership with the New Jersey Institute of Technology (NJIT) to co-develop and deliver graduate-level bioprocessing elective courses within NJIT’s Master of Science program in Chemical and Materials Engineering. The collaboration focuses on preparing students for roles in cell and gene therapy (CGT) manufacturing.
The courses, scheduled to launch in Spring 2027, will combine academic instruction with practical training aligned to current industry standards. Made Scientific will contribute expertise in advanced therapies and bioprocessing, alongside its Made Scientific Foundry™ scholar program, to support the development of curriculum designed for real-world manufacturing environments.
The initiative is intended to address workforce needs in the CGT sector by equipping graduate students with hands-on experience and technical knowledge applicable to clinical and commercial manufacturing settings. The program will integrate tools, workflows, and processes used in active manufacturing operations.
“By combining Made Scientific’s hands-on manufacturing expertise and our workforce development & training program with NJIT’s academic excellence, we are creating a truly differentiated learning experience — one that will produce industry-ready professionals capable of driving innovation in CGT manufacturing.”
Syed T. Husain, Chairman and CEO of Made Scientific
The partnership builds on an existing relationship between the two organizations, which originated through NJIT’s New Jersey Innovation Institute. Both parties stated that the collaboration supports workforce development and aims to strengthen capabilities in biomanufacturing through alignment between academic training and industry requirements.
